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SUMMARY
Introduction/Objective Although smoking is the main risk factor for lung cancer (LC), studies have 
shown that diet could also play an important role.
The objective of this study was to analyze dietary intake of newly diagnosed LC patients and to compare 
with sex- and age-matched healthy controls.
Methods Sixty-nine non-treated LC patients (50 male, 19 female, aged 46–80 years), and 70 healthy controls 
(50 male, 20 female, aged 47–76 years) filled out a validated food frequency questionnaire in the presence 
of a trained nutritionist. Nutrient intake was calculated using the Serbian Food Composition Database.
Results Similar energy intake was reported by both groups. However, the controls had significantly 
higher intake of total fats, saturated, monounsaturated, and n-3 polyunsaturated fatty acids (PUFAs) and 
lower intake of carbohydrates and n-6 PUFAs. Patients with LC reported markedly lower intake of milk 
and dairy products, eggs, seafood, vegetables, and fruits, and higher intake of grains and grain products. 
Conclusion Patients with LC had significantly different dietary intake of most nutrients compared to healthy 
participants, suggesting that changes in dietary patterns could contribute to prevention of LC development.
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INTRODUCTION
Lifestyle factors, including diet and smoking, 
have long been linked to cancer development. 
Observational epidemiological studies have re-
ported significant correlations between dietary 
habits and cancer incidence and mortality [1]. 
Since these risk factors are modifiable, changes in 
lifestyle can reduce cancer risk and can improve 
overall survival after diagnosis of some cancers. 
According to the latest recommendations, a diet 
for cancer prevention implies higher intake of 
fruits, vegetables, whole grains and pulses, with 
low amounts of red meat, no processed meats, 
and limited salt intake. In addition, a healthy diet 
implies the avoidance of sweetened drinks and 
limited intake of alcohol and energy-dense foods, 
thereby contributing to achieving and maintain-
ing a healthy weight, given that obesity is also a 
risk factor for several cancers [2]. This is in line 
with the results of a large European Prospective 
Investigation into Nutrition and Cancer (EPIC) 
study, where the participants with a lifestyle in 
agreement with the World Cancer Research Fund 
and the American Institute for Cancer Research 
recommendations for cancer prevention, had 
a 34% lower risk of death (95% CI: 0.59–0.75) 
compared to participants within the lowest agree-
ment to the recommendations [3].
The relationship between diet and cancer are 
complex. Many dietary components are con-
sumed every day worldwide, but the amounts 
of bioactive components within a particular food 
may widely vary [4]. Besides the potential of 
each food component to modify cancer process 
at different steps, the quantity, timing, duration 
of exposure, as well as combinations of several 
micronutrients can affect the cell response [2]. 
Therefore, the influence of different dietary in-
takes is probably a combination of effects on sev-
eral pathways involved in cancer development.
Increased risk of some cancer types is asso-
ciated with excessive caloric intake and obes-
ity, and experimental studies have shown that 
calorie restriction suppresses the carcinogen-
esis. Although underlying mechanisms are not 
clear, they may include chronic inflammation, 
oxidative stress, insulin resistance, changes in 
the metabolism of sex hormones, and increased 
production of cytokines by adipose tissue [5]. 
Diets rich in simple carbohydrates may promote 
carcinogenesis by increasing oxidative stress, 
insulin synthesis, and by forming adipose tissue, 
which is a source of inflammatory cytokines [6]. 
On the other hand, diet can also have anti-carci-
nogenic effects, especially in people who are ex-
posed to other environmental carcinogens [7]. 
Thus, it is important to evaluate dietary habits 
in people with cancer in comparison with ap-
parently healthy people of the same age.
Lung cancer (LC) is the leading cause of can-
cer-related death worldwide. The main risk fac-
tor for LC is cigarette smoking, which accounts 
for about 90% of cases [8]. Tobacco smoke con-
tains numerous reactive oxygen and nitrogen 
species that can induce oxidative damage of 
DNA and thus act as carcinogenic compounds 
[9]. On the other hand, antioxidant nutrients 
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(such as carotenoids, vitamin E, C, etc.) present in plant 
foods, scavenge free radicals and thereby protect DNA from 
oxidative damage caused by smoking. In this way, adequate 
diet might protect even smokers against LC. A potentially 
protective effect of fruits and vegetables was observed in 
numerous case-control and cohort studies, including the 
EPIC study [10], although the NIH-AARP North American 
cohort study did not find a significant association [11]. Evi-
dence of an inverse association between LC and the intake 
of carotenoid-rich vegetables was provided by the study in 
Chinese men [12]. In a multi-ethnic cohort, circulating car-
otenoid levels were inversely related to LC risk in men but 
not in women, raising the issue of potential confounding 
by smoking [13]. Nevertheless, the effects of other dietary 
components besides carotenoid have not been thoroughly 
investigated, and the convincing relationship between the 
diet and LC has not been established so far.
The aim of this study is to evaluate dietary intakes in 
newly diagnosed patients with LC and to compare them to 
the dietary intake reports of control participants. 
METHODS
Study population
This case-control study involved 69 patients with LC re-
cruited consecutively from June 2015 to September 2016 at 
the Bežanijska Kosa Clinical Hospital Center in Belgrade, 
Serbia. Among them, there were 50 male and 19 female 
patients, of the median age of 63 years (46–80 years). 
The inclusion criteria were histopathologically confirmed 
cell LC and willingness to complete the food frequency 
questionnaire, while the exclusion criteria were some other 
malignancy or serious chronic non-malignant diseases. The 
control group was composed of 70 apparently healthy age- 
and sex-matched participants, 50 men and 20 women, of the 
median age of 63 years (47–76 years). All study participants 
signed the informed consent approved by the Ethical Review 
Board of the Bežanijska Kosa Clinical Hospital Center, in ac-
cordance with the principles of the Declaration of Helsinki.
For all the patients we performed a fibreoptic bron-
choscopy and obtained a biopsy sample. Out of the total 
of 69 patients, non-small cell lung carcinoma was found 
in 41 patients (14 adenocarcinoma and 27 squamocellular 
carcinoma), small-cell lung carcinoma in 18, and 10 pa-
tients had some other kind of lung carcinoma (carcinoid, 
metastatic malignancy, mesenchymal malignancy).
Dietary intake 
Habitual dietary intake of patients and controls was assessed 
using a semi-quantitative, validated Food Frequency Ques-
tionnaire (FFQ) [14]. It was self-administered in the presence 
of a medical professional and it took approximately 30–40 
minutes to complete. The questionnaire consisted of 90 food 
items classified in appropriate groups and additional ques-
tions regarding socio-demographic characteristics, smoking 
status, medical condition, as well as dietary supplements and 
medication use. Subjects were asked to recall their dietary 
habits over the preceding three months. For each item, par-
ticipants reported their average frequency of consumption 
for the specified time period on a seven-level scale with 
frequency categories ranging from “never” to “every day.” 
Selected frequency option for each item was converted to 
a daily equivalent with reference to a baseline coefficient of 
1.0 for the “every day” category. Furthermore, for all items, 
participants indicated their usual portion size using standard 
measures, natural portions and pre-specified options pre-
sented in photographs incorporated in the questionnaire. 
Diet Assess & Plan, a software-based validated nutritional 
tool, was used to process the FFQs and obtain comprehensive 
dietary intake assessment [14]. Nutrient intake calculation 
was performed using the product-sum method. The esti-
mates of amounts of food consumed per day were multiplied 
with nutritional value of 100 g of that food according to the 
Serbian Food Composition Database [15]. 
Statistical analysis
The results are presented as the mean ± SD. Normality was 
tested using the Kolmogorov–Smirnov test. Unpaired Stu-
dent’s t-test was used to compare the normally distributed 
variables, and nonparametric Mann–Whitney U-test for 
non-normally distributed variable analysis. The differences 
between the patients and the control group were consid-
ered significant at p ≤ 0.05.
RESULTS
The characteristics of the study participants are presented in 
Table 1. Among 69 LC patients, 50 were male and 19 female, 
median age being 63.2 years (46–80 years). Forty-one patients 
had non-small-cell lung carcinoma, 18 had small-cell lung 
carcinoma, and 10 patients other types of LC. Smoking status 
differed between the groups. In the control group, 34 out of 70 
persons were smokers and ex-smokers. Among the patients, 
58 out of 69 were smokers and ex-smokers, and most of them 
(57) were heavy smokers with more than 20 pack-years.
The average daily intake of energy and macronutrients 
is displayed in Table 2. Mean daily energy intake in the 
patients group was 1,912 kcal, ranging 741–4,458 kcal/d. 
A similar energy intake was reported by the control group. 
However, the controls had significantly lower intake of 
carbohydrates and higher intake of total fats, saturated, 
monosaturated, and n-3 polyunsaturated fatty acids (PU-
FAs). Reported intake of total PUFAs in both groups was in 
a wide range; the group of patients had significantly higher 
intake of n-6 PUFAs than the group of healthy participants.
We found significant differences in the dietary habits 
between the two groups when we evaluated dietary in-
take according to food groups. Patients with LC reported 
markedly lower intakes of milk and dairy products, eggs, 
seafood, vegetables, and fruits, and higher intake of grains 
and grain products. Interestingly, higher sugar intake was 
reported by the controls. Dietary intake of specific food 
groups is presented in Table 3.
Dietary intake in newly diagnosed lung cancer patients
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This study has shown significant differences in dietary in-
take between apparently healthy controls and patients with 
newly diagnosed LC. To the best of our knowledge, this is 
the first study on the relationship between dietary habits 
and cancer in Serbia. Patients fulfilled validated FFQ on 
the dietary intake in the last three months before the diag-
nosis of LC. Nevertheless, their dietary habits significantly 
differed from those of the controls.
Epidemiological studies on associations between dietary 
intake or biomarkers of certain macro- and micronutrients 
and cancer risk have not revealed conclusive evidence. When 
comparing the intake among our study participants, we found 
similar energy and protein intake, but differences in the intake 
of carbohydrates and fats. The control group had markedly 
higher intake of all fats, in particular n-3 polyunsaturated fatty 
acids (PUFAs), but lower intake of n-6 PUFAs. LC patients 
had significantly lower intake of seafood, which is the best 
source of n-3 PUFAs, and nuts, seeds, and kernel products. 
Although the intake of fats and oils was similar in the two 
groups, the type of fats was different. In the LC group, 68 out 
of 69 patients reported daily intake of sunflower oil, which is 
the main source of n-6 PUFAs in our region. Twenty-seven 
of them occasionally consumed olive oil and only one out of 
69 patients exclusively used olive oil for food preparation. In 
the control group, 63 out of 70 subjects used sunflower oil, 
but 33 of them also consumed olive oil, while seven controls 
consumed only olive oil. Thus the ratio between n-6 and n-3 
PUFAs is significantly higher in the patient group. Dietary 
n-6/n-3 PUFAs ratio is an important additional factor for tu-
morigenesis [16]. Cancer-related research on essential fatty 
acids (EFAs) mostly focused on the beneficial properties and 
mechanisms of n-3 PUFAs and the n-6/n-3 ratio. However, 
a limited number of studies, to date, have evaluated habitual 
dietary intake of n-3 and n-6 PUFAs in LC patients. The anti-
cancer effects of long-chain n-3 PUFAs, specifically eicosap-
entaenoic acid (EPA, C20:5n-3) and docosahexaenoic acid 
(DHA, C22:6n-3), have been shown in several studies [17]. 
Namely, diet influences cell membrane lipid composition. 
The intake of n-3 PUFAs leads to their incorporation into 
membrane phospholipids [18]. EPA and DHA may alter the 
distribution or function of membrane-associated signaling 
molecules by inducing changes in physical properties of mem-
branes, they have important anti-inflammatory properties, 
and can act perhaps by some other mechanism [18]. Takezaki 
et al. [19] reported that cooked and raw fish consumption 
lowered the risk of lung adenocarcinoma in Japanese. Also, 
they showed that individuals who eat fish three or more times 
per week had an 81% lower risk of LC than those who do so 
less than once a week [19]. 
Cancer patients typically have lower levels of n-3 PUFAs 
in plasma phospholipids [20]. Moreover, they have worse 
prognosis and n-3 supplementation improves their response 
to therapy and clinical outcome [21]. Many clinical trials 
suggest improved outcomes with n-3 PUFA supplemen-
tation in LC patients undergoing chemotherapy [22, 23]. 
However, the mechanism how n-3 PUFAs selectively modify 
the response of tumor cells but not normal host tissues to 
chemotherapeutic agents remains to be elucidated. 
On the other hand, dietary-related disease caused by 
the excessive intake of n-6 PUFAs in the Western world 
has recently come to attention. Although linoleic acid 
(LA; C18:2 n-6) is as an EFA, it was associated with in-
creased cancer incidence and tumor progression [24]. It 
is interesting to note that LA supplementation upregulates 
pathways involving epidermal growth factor receptor and 
phosphoinositide 3-kinase, already major targets in can-
cer therapeutic development [25]. Mouradian et al. [26] 
Table 1. Demographic and clinical characteristic of the study participants
Variable LC patients Controls
No. (M/F) 50/19 50/20
Median age (years) 63.2 ± 7.9 63.1 ± 7.7
Smoking status
Smokers (M/F) 50 (39/11) 25 (19/6)





Other lung cancers 10 -
LC – lung cancer; M – male; F– female; NSCLC – non-small cell lung carcinoma; 
SCLC – small-cell lung carcinoma
Table 2. Dietary intake in study participants evaluated by the validated 
FFQ; significant statistical difference is determined by the unpaired 
Student’s t-test and Mann–Whitney U-test
Variable LC patients (range) Controls
Energy (kcal) 1,912 ± 644 (741–4,458)
1,931  ±  444 (1,109–
3,081)
Proteins (g) 85.3 ± 30.6 (35.9–169.4) 83.2 ± 21.5 (45–156.1)
Carbohydrates 
(g) 238.6 ± 87.5 (82.8–599.5) 210 ± 53.5 (74.2–434)*
Fats (g) 48.8 ± 21.1 (14.5–120) 63.5 ± 18.7 (27.7–119.3)**
SFA (g) 21.0 ± 11.9 (3.9–79.2) 26.1 ± 8.7 (12.0–54.1)*
MUFA (g) 23.0 ± 14.4 (4–99) 27.7 ± 11.7 (12.1–58.7)*
PUFA (g) 9.5 ± 3.9 (2.9–21) 10.8 ± 4.7 (4.1–25)
n-3 PUFA (mg) 594 ± 314 (78–1,633) 708 ± 210 (352–1,436)**
n-6 PUFA (mg) 5,340 ± 1,852  (1,828–9,346)
3,762 ± 1,763  
(1,793–11,305)**
Cholesterol (mg) 342 ± 203 (41–1,125) 392 ± 145 (141–770)
LC – lung cancer; SFA – saturated fatty acids; MUFA – monounsaturated fatty 
acids; PUFA – polyunsaturated fatty acids;  
*p < 0.05; **p < 0.001
Table 3. Dietary intake of specific food groups; significant statistical 
difference is determined by the unpaired Student’s t-test and Mann–
Whitney U-test
Food groups LC patients (g) Control (g)
Milk and dairy products 95 ± 103 168 ± 125***
Eggs 23 ± 22 35 ± 24**
Meat and meat products 156 ± 106 169 ± 56
Seafood 9 ± 12 18 ± 13***
Fat and oils 52 ± 32 54 ± 28
Grains and grain products 341 ± 139 228 ± 68***
Nuts, seeds, and kernel products 0.7 ± 0.9 3.4 ± 6.4***
Vegetables 160 ± 101 190 ± 61*
Fruits 158 ± 145 260 ± 148***
Sugar and candies 17 ± 22 28 ± 19***
LC – lung cancer; 
*p < 0.05; **p < 0.01; ***p < 0.001
Stojanović A. et al.
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have identified a series of signaling events initiated by the 
LA-induced upregulation of cyclooxygenase activity and 
prostaglandin E2 synthesis, which are involved in enhance-
ment of cell growth in models of human breast and LCs. 
In accordance with these findings, our patients with LC 
had higher n-6 PUFAs intake. This suggests that nutri-
tion, specifically dietary modifications of PUFAs intake, 
should be considered as an adjuvant treatment of cancer. 
Nevertheless, a recent meta-analysis of eight prospective 
cohort studies showed that a high PUFA intake was not 
associated with LC (risk ratio 0.91; 95% CI 0.78–1.06) [27], 
but the authors did not analyze n-3 and n-6 PUFAs sepa-
rately. This study has given two important inputs for future 
studies: to take cooking methods into account of assessing 
PUFA intake and to analyze the impact of PUFA intake on 
specific histological or cell types of LC, in order to provide 
clear dietary guidelines for the prevention.
Several studies have investigated the relationship between 
milk and dairy consumption and LC risk, but they have 
produced conflicting results. Two recent meta analyses have 
found no significant associations between intake of dairy 
products and the risk of LC [28, 29]. This is in accordance 
with our results that the control group had higher intake of 
milk and dairy products. However, it should be noted that 
both groups had consumption of these products below the 
current recommendations. Fruits and vegetables are tradi-
tionally recognized as cancer protective. In accordance, the 
control subjects had higher intake of vegetables and even 
more so of fruits than the LC patients. A recent meta-anal-
ysis of 18 studies has confirmed protective effects of vegeta-
bles and fruits intake and LC, with the summary risk ratio 
estimates of 0.86 (95% CI 0.78–0.94) [30]. The mechanisms 
of the anti-cancer effects of fruits and vegetables have not 
been thoroughly investigated. The suggested mechanisms 
are thought to be mediated by multiple components, such as 
beta-carotene, vitamins C and E, fiber, and phytochemicals, 
and include modulation of DNA methylation, protection 
against oxidative stress and DNA damage, promotion of 
apoptosis, and induction of detoxifying enzymes [7]. 
Although LC patients had lower intake of fruits, vegeta-
bles, and even sugars, they had higher intake of carbohy-
drates, which could be attributed to grains and grain prod-
ucts. There is some evidence that reducing dietary carbohy-
drate intake could suppress, or at least delay, the occurrence 
of cancer [31]. Also, the proliferation of already existing tu-
mor cells could slow down. In LC, studies have mostly been 
focused on fruit, vegetables, and related micronutrients, with 
little reference to carbohydrates. A recent study has revealed 
that people who often consume foods with high glycemic 
index (GI) had a 49% higher risk of developing LC, even 
if they are non-smokers [32]. However, our patients had a 
negligible intake of low GI foods (ground whole-wheat bread, 
rolled or steel-cut oatmeal, most fruits, and non-starchy veg-
etables) and higher intake of refined grains and higher GI 
foods (white bread, bakery products of refined wheat flour, 
white rice, potatoes). In line with this, higher consumption of 
whole grains and fruits was significantly inversely associated 
with LC risk for several of the diet indices [33]. A possible 
reason is that higher GI foods rapidly elevate blood glucose 
and insulin levels after a meal, which in turn raises insulin-
like growth factor 1 (IGF-1). IGF-1 can directly promote tu-
mor cell proliferation via the insulin/IGF-1 signaling pathway 
and thus is linked to an increased LC risk. 
The limitation of this study is a relatively low number 
of study participants. We did not calculate associations 
(odds ratios) between specific foods and LC, since the idea 
was to compare dietary habits between the patients and 
matched healthy subjects. In addition, dietary intake is 
assessed using FFQ after cancer diagnosis, and question-
naires are more prone to recall and selection biases than 
prospective observational studies.
CONCLUSION
Patients with LC had significantly different dietary intake 
of most nutrients compared to healthy participants, sug-
gesting that changes in dietary patterns could contribute 
to prevention of LC development.
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САЖЕТАК
Увод/Циљ Иако је пушење водећи фактор ризика за рак 
плућа (РП), студије показују да и начин исхране игра важну 
улогу. 
Циљ ове студије је да се анализа исхрана код болесника 
са новодијагностикованим РП и да се упореди са здравом 
популацијом истог пола и година старости.
Методе Шездесет девет болесника са новооткривеним РП 
(50 мушкараца, 19 жена, старости 46–80 година) и 70 здравих 
испитаника (50 мушкараца, 20 жена, старости 47–76 година) 
попунило је у присуству лекара упитник о учесталости кон-
зумирања намирница. Нутритивни унос је рачунат помоћу 
Српске базе података о саставу намирница.
Резултати Обе групе су имале сличан унос енергије, али је 
у контролној групи забележен већи унос масти, засићених, 
мононезасићених и н-3 полинезасићених масних киселина 
(ПНМК), а нижи унос угљених хидрата и н-6 ПНМК. Група 
болесника је имала значајно нижи унос млека и млечних 
производа, јаја, морских плодова, воћа и поврћа, а већи 
унос житарица и производа од брашна.
Закључак Болесници са РП имали су значајно другачији 
начин исхране од здравих испитаника, што сугерише да 
промене у начину исхране могу да допринесу превенцији 
настанка канцера плућа.
Кључне речи: канцер плућа; исхрана; упитник о учеста-
лости конзумирања намирница; масне киселине 
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